Integer (NYSE:ITGR) Price Target Raised to $144.00

Integer (NYSE:ITGR) had its price objective boosted by analysts at KeyCorp from $139.00 to $144.00 in a research report issued on Tuesday, Benzinga reports. The firm currently has an “overweight” rating on the medical equipment provider’s stock. KeyCorp’s target price indicates a potential upside of 9.87% from the company’s current price.

A number of other analysts have also weighed in on ITGR. Truist Financial raised their target price on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research report on Monday. Citigroup raised their price target on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Benchmark reaffirmed a “buy” rating and set a $130.00 price target on shares of Integer in a research note on Wednesday, October 2nd. Oppenheimer assumed coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target for the company. Finally, Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. One analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $138.71.

Integer Stock Performance

Shares of Integer stock opened at $131.06 on Tuesday. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $133.53. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market capitalization of $4.39 billion, a P/E ratio of 45.35, a P/E/G ratio of 1.86 and a beta of 1.08. The company’s 50 day moving average price is $126.20 and its two-hundred day moving average price is $120.41.

Integer (NYSE:ITGR) last issued its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same quarter last year, the business posted $1.14 earnings per share. The company’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities analysts forecast that Integer will post 5.3 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now owns 2,280 shares of the company’s stock, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 2.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integer

A number of hedge funds have recently bought and sold shares of ITGR. Creative Planning grew its holdings in Integer by 22.2% in the third quarter. Creative Planning now owns 9,077 shares of the medical equipment provider’s stock worth $1,180,000 after purchasing an additional 1,650 shares during the period. Contravisory Investment Management Inc. grew its holdings in Integer by 55.9% in the third quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the period. High Note Wealth LLC grew its holdings in Integer by 66.8% in the third quarter. High Note Wealth LLC now owns 3,200 shares of the medical equipment provider’s stock worth $416,000 after purchasing an additional 1,282 shares during the period. Azzad Asset Management Inc. ADV grew its holdings in Integer by 0.9% in the third quarter. Azzad Asset Management Inc. ADV now owns 11,572 shares of the medical equipment provider’s stock worth $1,504,000 after purchasing an additional 107 shares during the period. Finally, GAMMA Investing LLC grew its holdings in Integer by 74.1% in the third quarter. GAMMA Investing LLC now owns 653 shares of the medical equipment provider’s stock worth $85,000 after purchasing an additional 278 shares during the period. Institutional investors own 99.29% of the company’s stock.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.